Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sullivan

Showing results (1021-1030 of 1,433) with videos related to

Pageof 144
Sort By:
Annals of Neurology|July 16, 2011
Predictors of seizure freedom after surgery for malformations of cortical developmentEdward F Chang, Doris D Wang, A James Barkovich, et al.
Journal of Clinical Immunology|February 18, 2020
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and ManagementNicholas Brodszki, Ashley Frazer-Abel, Anete S Grumach, et al.
European Heart Journal. Acute Cardiovascular Care|November 27, 2020
Use of hospital resources in the care of patients with intermediate risk pulmonary embolismAlexander E Sullivan, Tara Holder, Tracy Truong, et al.
International Immunopharmacology|July 30, 2024
EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupusPaul M Gallo, Robert W Chain, Jun Xu, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2023
Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registryJose Alfredo Méndez Barrera, Samuel Rocha Guzmán, Elisa Hierro Cascajares, et al.
Journal of Substance Abuse Treatment|October 16, 2007
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan, Brent A Moore, Marek C Chawarski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan, Michael Botsko, Chinazo O Cunningham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patientsPamela Vergara-Rodriguez, Mary Jo Tozzi, Michael Botsko, et al.
Allergy|July 4, 2019
Toll-like receptor 2 stimulation augments esophageal barrier integrityMelanie A Ruffner, Li Song, Kelly Maurer, et al.
Vascular Pharmacology|March 6, 2003
Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosisYi-Xin Wang, Rick Fitch, Weiwei Li, et al.
Pageof 144

Showing results (1021-1030 of 1,433) with videos related to

Sort By:
Pageof 144
Annals of Neurology|July 16, 2011
Predictors of seizure freedom after surgery for malformations of cortical developmentEdward F Chang, Doris D Wang, A James Barkovich, et al.
Journal of Clinical Immunology|February 18, 2020
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and ManagementNicholas Brodszki, Ashley Frazer-Abel, Anete S Grumach, et al.
European Heart Journal. Acute Cardiovascular Care|November 27, 2020
Use of hospital resources in the care of patients with intermediate risk pulmonary embolismAlexander E Sullivan, Tara Holder, Tracy Truong, et al.
International Immunopharmacology|July 30, 2024
EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupusPaul M Gallo, Robert W Chain, Jun Xu, et al.
Clinical Immunology (Orlando, Fla.)|September 7, 2023
Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registryJose Alfredo Méndez Barrera, Samuel Rocha Guzmán, Elisa Hierro Cascajares, et al.
Journal of Substance Abuse Treatment|October 16, 2007
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan, Brent A Moore, Marek C Chawarski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan, Michael Botsko, Chinazo O Cunningham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patientsPamela Vergara-Rodriguez, Mary Jo Tozzi, Michael Botsko, et al.
Allergy|July 4, 2019
Toll-like receptor 2 stimulation augments esophageal barrier integrityMelanie A Ruffner, Li Song, Kelly Maurer, et al.
Vascular Pharmacology|March 6, 2003
Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosisYi-Xin Wang, Rick Fitch, Weiwei Li, et al.
Pageof 144